LB Prescription drugs Co., Ltd. (LBRX) twenty fifth Annual Needham Digital Healthcare Convention April 16, 2026 11:45am EDT
Taking part corporations
Heather Turner – CEO and Director
Convention name individuals
Ami Fadia – Needham & Firm, LLC, Analysis Division
presentation
Ami Fadia
Needham & Firm, LLC, Analysis Division
Good morning everybody. I am Ami Fadia, a biotechnology analyst at Needham. Welcome to our subsequent session with LB Prescription drugs. We’re proud to welcome our CEO, Heather Turner.
Heather, thanks a lot for becoming a member of us on the convention and taking the time for this session. We are going to offer you this materials on your presentation, and there might be time for a query and reply session on the finish. And possibly this can be a good time to remind our listeners that if they’ve any questions they need to ask me, they’ll ship them by means of the dashboard.
So, I am going to go it to you, Heather.
heather turner
Consultant Director and President
Ami, thanks for becoming a member of us at this convention immediately. We’re actually blissful to be becoming a member of Zoomaverse with you all. I wish to make a optimistic assertion immediately.
LB Pharma’s imaginative and prescient is to construct a completely built-in firm centered on CNS-related ailments. This firm might be prepared, prepared and able to efficiently launching therapeutics as soon as we now have authorized belongings. We’ve got late-stage belongings LB-102 for schizophrenia, bipolar melancholy, and ancillary MDD.
Final yr, we introduced Section II knowledge from a schizophrenia scientific trial. As such, we consider there is a chance to determine a extremely differentiated profile in a really giant branded antipsychotic market. After finishing the Section II trial, we labored with the FDA. And we consider this involvement supplies an inexpensive path to approval for schizophrenia in only one Section III scientific trial.
we
